English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans

Held, K., Antonijevic, I., Künzel, H., Uhr, M., Wetter, T., Golly, I., et al. (2002). Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 35(4), 135-143.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Pharmacopsychiatry

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Held, K1, Author
Antonijevic, IA1, Author
Künzel, H1, Author
Uhr, M1, Author
Wetter, TC1, Author
Golly, IC1, Author
Steiger, A1, Author
Murck, H1, Author
Affiliations:
1Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137              

Content

show
hide
Free keywords: -
 Abstract: The process of normal aging is accompanied by changes in sleep- related endocrine activity. During aging, an increase in cortisol at its nadir and a decrease in renin and aldosterone concentration occur. In aged subjects, more time is spent awake and slow-wave sleep is reduced; there is a loss of sleep spindles and accordingly a loss of power in the sigma frequency range. Previous studies could show a close association between sleep architecture, especially slow-wave sleep, and activity in the glutamatergic and GABAergic system. Furthermore, recent studies could show that the natural N-methyl-D-aspartate (NMDA) antagonist and GABA(A) agonist Mg2+ seems to play a key role in the regulation of sleep and endocrine systems such as the HPA system and renin-angiotensin-aldosterone system (RAAS). Therefore, we examined the effect of Mg2+ in 12 elderly subjects (age range 60 - 80 years) on the sleep electroencephalogram (EEG) and nocturnal hormone secretion. A placebo-controlled, randomised crossover design with two treatment intervals of 20 days duration separated by 2 weeks washout was used. Mg2+ was administered as effervescent tablets in a creeping dose of 10 mmol and 20 mmol each for 3 days followed by 30 mmol for 14 days. At the end of each interval, a sleep EEG was recorded from 11 p.m. to 7 a.m. after one accommodation night. Blood samples were taken every 30 min between 8 p.m. and 10 p.m. and every 20 min between 10 p. m. and 7 a.m. to estimate ACTH, cortisol, renin and aldosterone plasma concentrations, and every hour for arginine-vasopressin (AVP) and angiotensin 11 (ATII) plasma concentrations. Mg2+ led to a significant increase in slow wave sleep (16.5 +/- 20.4 min vs. 10.1 +/- 15.4 min, p less than or equal to 0.05), delta power (47128.7 muV(2) +/- 21417.7 muV(2) vs. 37862.1 muV(2) 2 241.7 muV(2), p less than or equal to 0.05) and sigma power (1923.0 muV(2) +/- 1111.3 muV(2)vs. 1541.0 muV(2) +/- 1134.5 muV(2), p less than or equal to 0.05). Renin increased (3.7 +/- 2.3 ng/ml x min vs. 2.3 1.0 ng/ml x min, p < 0.05) during the total night and aldosterone (3.6 +/- 4.7 ng/ml x min vs. 1.1 0.9 ng/ml x min, p < 0.05) in the second half of the night, whereas cortisol (8.3 +/- 2.4 mug/ml x min vs. 11.8 +/- 3.8 mug/ml x min, p < 0.01) decreased significantly and AVP by trend in the first part of the night. ACTH and ATII were not altered. Our results suggest that Mg2+ partially reverses sleep EEG and nocturnal neuroendocrine changes occurring during aging. The similarities of the effect of Mg2+ and that of the related electrolyte Li+ furthermore supports the possible efficacy of Mg2+ as a mood stabilize

Details

show
hide
Language(s): eng - English
 Dates: 2002-07
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 4103
ISI: 000177376900002
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Pharmacopsychiatry
  Alternative Title : Pharmacopsychiatry
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 35 (4) Sequence Number: - Start / End Page: 135 - 143 Identifier: ISSN: 0176-3679